Trends of Non‐Hodgkin Lymphoma Incidence Among Adults in the United States From 2000 to 2020
Cancer Reports · 2025
DOI: 10.1002/cnr2.70269 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Reports, 2025. Verfasst von Armin Aslani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Social Determinants of Health Research Center, Department of Community Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, …. Hauptthemen laut MEDLINE: COVID-19, Lymphoma, Non-Hodgkin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Non‐Hodgkin lymphoma (NHL) comprises a broad range of hematologic cancers originating from lymphoid tissues. It ranks among the 10 most frequently diagnosed cancers in the United States (US).
Aims
This study aims to analyze trends in the incidence of adult NHL in the US from 2000 to 2020, considering factors such as age, sex, race/ethnicity, and histological subtypes. Additionally, the impact of the COVID‐19 pandemic on these incidence trends was explored. Methods and Results Data from the Surveillance, Epidemiology, and End Results program were utilized to examine the age‐standardized incidence rates (ASIR) of NHL. Joinpoint regression modeling was applied to calculate the annual percent change (APC) and the average annual percent change (AAPC) of ASIRs over the period from 2000 to 2020. From 2000 to 2019, a total of 962 535 NHL were reported among all ages in the US. They were mostly B‐cell NHL (93.59%), in Non‐Hispanic Whites (73.31%), and individuals aged 70–79 (25.94%). The overall ASIRs were 55.58 (55.43, 55.73) for men and 36.00 (35.89, 36.11) for women. There was a notable decline in ASIRs following the onset of the COVID‐19 pandemic from 2019 to November 2020, with a percentage change of −10.52% (−11.60, −9.45). The overall AAPC for adult NHL was 0.45% (0.33, 0.62) in men and 0.38% (0.21, 0.57) in women, indicating a minimal yet significant increase.
Conclusion
NHL incidence increased over 2000–2019. These trends in incidence rates exhibited variation across different races, sexes, age groups, and histological subtypes. COVID‐19 led to a decrease in NHL incidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Social Determinants of Health Research Center, Department of Community Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
- Center for Orthopedic Trans-Disciplinary Applied Research, Tehran University of Medical Sciences, Tehran, Iran.
- Neurosciences Research Center, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
- School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
- Calaveras County Department of Health, Calaveras County, California, USA.
- HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
ORCID-Profile: Armin Aslani, Morvarid Najafi, Seyed Ehsan Mousavi, Hanieh Marandi, Zahra Yekta, Seyed Aria Nejadghaderi
Zitieren
APA
Aslani, A., Najafi, M., Mousavi, S. E., Marandi, H., Yekta, Z., & Nejadghaderi, S. A. (2025). Trends of Non‐Hodgkin Lymphoma Incidence Among Adults in the United States From 2000 to 2020. Cancer Reports. https://doi.org/10.1002/cnr2.70269
Vancouver
Aslani A, Najafi M, Mousavi SE, Marandi H, Yekta Z, Nejadghaderi SA. Trends of Non‐Hodgkin Lymphoma Incidence Among Adults in the United States From 2000 to 2020. Cancer Reports. 2025. doi:10.1002/cnr2.70269
BibTeX
@article{Aslani2025,
author = {Aslani, Armin and Najafi, Morvarid and Mousavi, Seyed Ehsan and Marandi, Hanieh and Yekta, Zahra and Nejadghaderi, Seyed Aria},
title = {Trends of Non‐Hodgkin Lymphoma Incidence Among Adults in the United States From 2000 to 2020},
journal = {Cancer Reports},
year = {2025},
doi = {10.1002/cnr2.70269}
}
EUVIMED